Genetic Technologies Ltd/ US37185R4065 /
5/14/2024 5:03:15 PM | Chg. -0.17 | Volume | Bid10:25:00 PM | Ask10:25:00 PM | High | Low |
---|---|---|---|---|---|---|
2.27USD | -6.97% | 459 Turnover: 1,041.93 |
2.01Bid Size: 3 | -Ask Size: - | 2.27 | 2.27 |
GlobeNewswire
5/14
Metagenomi Presents Data at Scientific Conferences and First Quarter 2024 Financial Results
GlobeNewswire
5/14
Tenaya Therapeutics Reports First Quarter 2024 Financial Results and Provides Business Update
GlobeNewswire
5/14
QIAGEN receives European IVDR certification for QIAGEN Clinical Insight Interpret, its medical devic...
GlobeNewswire
5/14
PepGen Reports First Quarter 2024 Financial Results and Recent Corporate Highlights
GlobeNewswire
5/14
Taysha Gene Therapies Reports First Quarter 2024 Financial Results and Provides Corporate Update
GlobeNewswire
5/14
Korro Reports First Quarter 2024 Financial Results and Appointment of Kemi Olugemo, M.D. as Chief Me...
GlobeNewswire
5/14
Beam Therapeutics to Present Data Highlighting Robust Manufacturing Process for BEAM-101 at 2024 Eur...
GlobeNewswire
5/14
Aprea Therapeutics Reports First quarter 2024 Financial Results and Provides a Business Update
GlobeNewswire
5/14
Palisade Bio Reports First Quarter 2024 Financial Results and Provides Business Update
GlobeNewswire
5/14
Kura Oncology Completes Enrollment in Registration-Directed Trial of Ziftomenib in NPM1-Mutant AML
GlobeNewswire
5/14
BridgeBio Pharma to Participate in the Bank of America Merrill Lynch Global Healthcare Conference 20...
GlobeNewswire
5/14
Gain Therapeutics Reports Financial Results for First Quarter 2024 and Provides Corporate Update
GlobeNewswire
5/14
Tavros Therapeutics Achieves Two Milestone Payments in its Collaboration with Vividion Therapeutics
GlobeNewswire
5/14
ElevateBio Announces New U.S. Patents for Lead Life Edit CRISPR Systems and Adenine Deaminases Enabl...
GlobeNewswire
5/13
Generation Bio Announces Recent Business Highlights and First Quarter 2024 Financial Results
Newsfile Corp
5/13
One of 2024's Must Read Memoirs About the Life of a Mother, Wife, and Caregiver Is 'Notes from a Bla...
GlobeNewswire
5/13
Baylor Genetics Launches RNASeq Test for Whole Genome and Whole Exome Sequencing, Reduces Turnaround...
GlobeNewswire
5/13
Prime Medicine to Present at H.C. Wainwright 2nd Annual BioConnect Investor Conference at NASDAQ
GlobeNewswire
5/13
BridgeBio Pharma Presents Additional Data and Analyses from its Phase 3 ATTRibute-CM Study in Transt...
GlobeNewswire
5/13
Walden Biosciences Announces Research Collaboration with World Renowned Genetic Epidemiologist to Ad...
GlobeNewswire
5/10
Praxis Precision Medicines to Report First Quarter 2024 Financial Results on Monday, May 13, 2024
GlobeNewswire
5/10
Prime Medicine Reports First Quarter 2024 Financial Results and Provides Business Updates